DOI QR코드

DOI QR Code

Exosome-derived microRNA-29c Induces Apoptosis of BIU-87 Cells by Down Regulating BCL-2 and MCL-1

  • Xu, Xiang-Dong (Department of Urology, The First Affiliated Hospital of Chongqing Medical University) ;
  • Wu, Xiao-Hou (Department of Urology, The First Affiliated Hospital of Chongqing Medical University) ;
  • Fan, Yan-Ru (College of Laboratory Medicine of Chongqing Medical University) ;
  • Tan, Bing (Department of Urology, The First Affiliated Hospital of Chongqing Medical University) ;
  • Quan, Zhen (Department of Urology, The First Affiliated Hospital of Chongqing Medical University) ;
  • Luo, Chun-Li (College of Laboratory Medicine of Chongqing Medical University)
  • Published : 2014.04.30

Abstract

Background: Aberrant expression of the microRNA-29 family is associated with tumorigenesis and cancer progression. As transport carriers, tumor-derived exosomes are released into the extracellular space and regulate multiple functions of target cells. Thus, we assessed the possibility that exosomes could transport microRNA-29c as a carrier and correlations between microRNA-29c and apoptosis of bladder cancer cells. Materials and Methods: A total of 28 cancer and adjacent tissues were examined by immunohistochemistry to detect BCL-2 and MCL-1 expression. Disease was Ta-T1 in 12 patients, T2-T4 in 16, grade 1 in 8, 2 in 8 and 3 in 12. The expression of microRNA-29c in cancer tissues was detected by quantitative reverse transcriptase PCR (QRT-PCR). An adenovirus containing microRNA-29c was used to infect the BIU-87 human bladder cancer cell line. MicroRNA-29c in exosomes was measured by QRT-PCR. After BIU-87 cells were induced by exosomes-derived microRNA-29c, QRT-PCR was used to detect the level of microRNA-29c. Apoptosis was examined by flow cytometry and BCL-2 and MCL-1 mRNA expressions were assessed by reverse transcription-polymerase chain reaction. Western blotting was used to determine the protein expression of BCL-2 and MCL-1. Results: The expressions of BCL-2 and MCL-1 protein were remarkably increased in bladder carcinoma (p<0.05), but was found mainly in the basal and suprabasal layers in adjacent tissues. The expression of microRNA-29c in cancer tissues was negatively correlated with the BCL-2 and MCL-1. The expression level of microRNA-29c in exosomes and BIU-87 cells from the experiment group was higher than that in control groups (p<0.05). Exosome-derived microRNA-29c induced apoptosis (p<0.01). Although only BCL-2 was reduced at the mRNA level, both BCL-2 and MCL-1 were reduced at the protein level. Conclusions: Human bladder cancer cells infected by microRNA-29c adenovirus can transport microRNA-29c via exosomes. Moreover, exosome-derived microRNA29c induces apoptosis in bladder cancer cells by down-regulating BCL-2 and MCL-1.

References

  1. Wang Y, Zhang X, Li H, et al (2013). The role of miRNA-29 family in cancer. European J Cell Biol, 92, 123-8. https://doi.org/10.1016/j.ejcb.2012.11.004
  2. Mittelbrunn M, Gutiérrez-Vázquez C, Villarroya-Beltri C, et al (2011). Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun, 2, 282. https://doi.org/10.1038/ncomms1285
  3. Park SY, Lee JH, Ha M, et al (2008). miR-29 miRNAs activate p53 by targeting p85 and CDC42. Nature Structural & Molecular Biology, 16, 23-9.
  4. Reid G, Kirschner MB, van Zandwijk N (2011). Review Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol, 80, 193-208. https://doi.org/10.1016/j.critrevonc.2010.11.004
  5. Wang G, Zhang Hh, He Hd, et al (2010). Up-regulation of microRNA in bladder tumor tissue is not common. Int Urol Nephrol, 42, 95-102 https://doi.org/10.1007/s11255-009-9584-3
  6. Xiong Y, Fang JH, Yun JP, et al (2010). Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology, 51, 836-45.
  7. Zhang JX, Qian D, Wang FW, et al (2013). MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy. Cancer Letters, 329, 91-8. https://doi.org/10.1016/j.canlet.2012.10.033
  8. Zhao BS, Liu SG, Wang TY, et al (2013). Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev, 14, 139-43. https://doi.org/10.7314/APJCP.2013.14.1.139
  9. Garzon R , Liu S , Fabbri M, et al (2009). MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood, 113, 6411-8. https://doi.org/10.1182/blood-2008-07-170589
  10. Friedman JM, Liang G, Liu CC, et al (2009). The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res, 69, 2623-9. https://doi.org/10.1158/0008-5472.CAN-08-3114
  11. Fan W, Tian XD, Huang E, et al (2013). Exosomes from CIITAtransfected CT26 cells enhance anti- tumor effects. Asian Pac J Cancer Prev, 14, 987-91. https://doi.org/10.7314/APJCP.2013.14.2.987
  12. Garzon R, Heaphy CE, Havelange V, et al (2009), MicroRNA 29b functions in acute myeloid leukemia. Blood, 219, 214-21.
  13. Hu G, Yao H, Chaudhuri AD, et al (2012). Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphinemediated neuronal dysfunction. Cell Death Dis, 3, 381. https://doi.org/10.1038/cddis.2012.114
  14. Jamiyandorj U, Bae JS, Noh SJ, et al (2013). Expression of peptidyl-prolyl isomerase PIN1 and its role in the pathogenesis of extrahepatic cholangiocarcinoma. Oncol Lett November, 6, 1421-6.
  15. Kozomara A, Griffiths-Jones S (2011). miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Re, 39, 152-7.
  16. Kosaka N, Iguchi H, Yoshioka Y, et al (2010). Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem , 285, 17442-52. https://doi.org/10.1074/jbc.M110.107821
  17. Liu YQ, Li Y, Qin J, et al (2014). Matrine reduces proliferation of human lung cancer cells by inducing apoptosis and changing miRNA expression profiles. Asian Pac J Cancer Prev, 15, 2169-77. https://doi.org/10.7314/APJCP.2014.15.5.2169
  18. Mott JL, Kobayashi S, Bronk SF, et al (2007). Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene, 26, 6133-40. https://doi.org/10.1038/sj.onc.1210436
  19. Alvarez-Erviti L, Seow Y, Yin HF, et al (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol, 29, 341-5. https://doi.org/10.1038/nbt.1807
  20. Baffa R, Fassan M, Volinia S, et al (2009). MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol, 219, 214-21. https://doi.org/10.1002/path.2586
  21. Calin GA, Ferracin M, Cimmino A, et al (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med, 353, 1793-801. https://doi.org/10.1056/NEJMoa050995
  22. Castilla MA, Moreno-Bueno G, Romero-Perez L, et al (2011). Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol, 223, 72-80. https://doi.org/10.1002/path.2802
  23. Chaput N, Schartz NE, Andre F, et al (2004). Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol, 172, 2137-46. https://doi.org/10.4049/jimmunol.172.4.2137
  24. Ciesla M, Skrzypek K, Kozakowska M, et al (2011). Review MicroRNAs as biomarkers of disease onset. Anal Bioanal Chem, 401, 2051-61. https://doi.org/10.1007/s00216-011-5001-8
  25. Dyrskjøt L, Ostenfeld MS, Bramsen JB, et al (2009). Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res, 69, 4851-60. https://doi.org/10.1158/0008-5472.CAN-08-4043

Cited by

  1. MicroRNA-328 Inhibits Proliferation of Human Melanoma Cells by Targeting TGFB2 vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1575
  2. MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability vol.32, pp.1, 2015, https://doi.org/10.1007/s12032-014-0342-8
  3. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets vol.18, pp.7, 2017, https://doi.org/10.3390/ijms18071514
  4. Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia vol.8, pp.11, 2017, https://doi.org/10.1038/cddis.2017.520
  5. Effect of exosomal miRNA on cancer biology and clinical applications vol.17, pp.1, 2018, https://doi.org/10.1186/s12943-018-0897-7
  6. MicroRNAs in Smoking-Related Carcinogenesis: Biomarkers, Functions, and Therapy vol.7, pp.5, 2018, https://doi.org/10.3390/jcm7050098